{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:22:54Z","timestamp":1790871774280,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The WW domain\u2013containing oxidoreductase (WWOX) gene is located at FRA16D, a common fragile site involved in human cancer. Targeted deletion of Wwox in mice causes increased spontaneous tumor incidence, confirming that WWOX is a bona fide tumor suppressor gene. We show that stable transfection of WWOX into human PEO1 ovarian cancer cells, containing homozygous WWOX deletion, abolishes in vivo tumorigenicity, but this does not correlate with alteration of in vitro growth. Rather, WWOX restoration in PEO1, or WWOX overexpression in SKOV3 ovarian cancer cells, results in reduced attachment and migration on fibronectin, an extracellular matrix component linked to peritoneal metastasis. Conversely, siRNA-mediated knockdown of endogenous WWOX in A2780 ovarian cancer cells increases adhesion to fibronectin. In addition, whereas there is no WWOX-dependent difference in cell death in adherent cells, WWOX-transfected cells in suspension culture display a proapoptotic phenotype. We further show that WWOX expression reduces membranous integrin \u03b13 protein but not integrin \u03b13 mRNA levels, and that adhesion of PEO1 cells to fibronectin is predominantly mediated through integrin \u03b13. We therefore propose that WWOX acts as an ovarian tumor suppressor by modulating the interaction between tumor cells and the extracellular matrix and by inducing apoptosis in detached cells. Consistent with this, the suppression of PEO1 tumorigenicity by WWOX can be partially overcome by implanting these tumor cells in Matrigel. These data suggest a possible role for the loss of WWOX in the peritoneal dissemination of human ovarian cancer cells. [Cancer Res 2009;69(11):4835\u201342]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-2974","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T22:49:14Z","timestamp":1242773354000},"page":"4835-4842","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["<i>WWOX<\/i>\n                    Gene Expression Abolishes Ovarian Cancer Tumorigenicity\n                    <i>In vivo<\/i>\n                    and Decreases Attachment to Fibronectin via Integrin \u03b13"],"prefix":"10.1158","volume":"69","author":[{"given":"Charlie","family":"Gourley","sequence":"first","affiliation":[{"name":"1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.W.","family":"Paige","sequence":"additional","affiliation":[{"name":"2Ovarian Cancer Action (HHMT) Research Centre, Department of Oncology, Division of Surgery, Oncology, Reproductive Biology, and Anaesthetics, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Ward","sequence":"additional","affiliation":[{"name":"1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kuske","sequence":"additional","affiliation":[{"name":"1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"2Ovarian Cancer Action (HHMT) Research Centre, Department of Oncology, Division of Surgery, Oncology, Reproductive Biology, and Anaesthetics, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Sun","sequence":"additional","affiliation":[{"name":"2Ovarian Cancer Action (HHMT) Research Centre, Department of Oncology, Division of Surgery, Oncology, Reproductive Biology, and Anaesthetics, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Janczar","sequence":"additional","affiliation":[{"name":"2Ovarian Cancer Action (HHMT) Research Centre, Department of Oncology, Division of Surgery, Oncology, Reproductive Biology, and Anaesthetics, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Harrison","sequence":"additional","affiliation":[{"name":"1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morwenna","family":"Muir","sequence":"additional","affiliation":[{"name":"1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Smyth","sequence":"additional","affiliation":[{"name":"1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Gabra","sequence":"additional","affiliation":[{"name":"2Ovarian Cancer Action (HHMT) Research Centre, Department of Oncology, Division of Surgery, Oncology, Reproductive Biology, and Anaesthetics, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,6,1]]},"reference":[{"key":"2022061700292561900_B1","doi-asserted-by":"crossref","unstructured":"Smith DI, McAvoy S, Zhu Y, Perez DS. Large common fragile site genes and cancer. Semin Cancer Biol\u20082007; 17: 31\u201341.","DOI":"10.1016\/j.semcancer.2006.10.003"},{"key":"2022061700292561900_B2","unstructured":"Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res\u20082000; 60: 2140\u20135."},{"key":"2022061700292561900_B3","unstructured":"Paige AJ, Taylor KJ, Stewart A, et al. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res\u20082000; 60: 1690\u20137."},{"key":"2022061700292561900_B4","doi-asserted-by":"crossref","unstructured":"Paige AJ, Taylor KJ, Taylor C, et al. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A\u20082001; 98: 11417\u201322.","DOI":"10.1073\/pnas.191175898"},{"key":"2022061700292561900_B5","unstructured":"Kuroki T, Trapasso F, Shiraishi T, et al. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res\u20082002; 62: 2258\u201360."},{"key":"2022061700292561900_B6","unstructured":"Yendamuri S, Kuroki T, Trapasso F, et al. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res\u20082003; 63: 878\u201381."},{"key":"2022061700292561900_B7","doi-asserted-by":"crossref","unstructured":"Gourley C, Paige AJ, Taylor KJ, et al. WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear. Int J Oncol\u20082005; 26: 1681\u20139.","DOI":"10.3892\/ijo.26.6.1681"},{"key":"2022061700292561900_B8","doi-asserted-by":"crossref","unstructured":"Driouch K, Prydz H, Monese R, Johansen H, Lidereau R, Frengen E. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene\u20082002; 21: 1832\u201340.","DOI":"10.1038\/sj.onc.1205273"},{"key":"2022061700292561900_B9","doi-asserted-by":"crossref","unstructured":"Aqeilan RI, Kuroki T, Pekarsky Y, et al. Loss of WWOX expression in gastric carcinoma. Clin Cancer Res\u20082004; 10: 3053\u20138.","DOI":"10.1158\/1078-0432.CCR-03-0594"},{"key":"2022061700292561900_B10","unstructured":"Bednarek AK, Keck-Waggoner CL, Daniel RL, et al. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res\u20082001; 61: 8068\u201373."},{"key":"2022061700292561900_B11","doi-asserted-by":"crossref","unstructured":"Fabbri M, Iliopoulos D, Trapasso F, et al. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci U S A\u20082005; 102: 15611\u20136.","DOI":"10.1073\/pnas.0505485102"},{"key":"2022061700292561900_B12","doi-asserted-by":"crossref","unstructured":"Qin HR, Iliopoulos D, Semba S, et al. A role for the WWOX gene in prostate cancer. Cancer Res\u20082006; 66: 6477\u201381.","DOI":"10.1158\/0008-5472.CAN-06-0956"},{"key":"2022061700292561900_B13","doi-asserted-by":"crossref","unstructured":"Aqeilan RI, Trapasso F, Hussain S, et al. Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci U S A\u20082007; 104: 3949\u201354.","DOI":"10.1073\/pnas.0609783104"},{"key":"2022061700292561900_B14","doi-asserted-by":"crossref","unstructured":"Aqeilan RI, Hagan JP, Aqeilan HA, Pichiorri F, Fong LY, Croce CM. Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo. Cancer Res\u20082007; 67: 5606\u201310.","DOI":"10.1158\/0008-5472.CAN-07-1081"},{"key":"2022061700292561900_B15","doi-asserted-by":"crossref","unstructured":"Ludes-Meyers JH, Kil H, Nunez MI, et al. WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer\u20082007; 46: 1129\u201336.","DOI":"10.1002\/gcc.20497"},{"key":"2022061700292561900_B16","doi-asserted-by":"crossref","unstructured":"Aqeilan RI, Pekarsky Y, Herrero JJ, et al. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci U S A\u20082004; 101: 4401\u20136.","DOI":"10.1073\/pnas.0400805101"},{"key":"2022061700292561900_B17","doi-asserted-by":"crossref","unstructured":"Chang NS, Pratt N, Heath J, et al. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem\u20082001; 276: 3361\u201370.","DOI":"10.1074\/jbc.M007140200"},{"key":"2022061700292561900_B18","doi-asserted-by":"crossref","unstructured":"Nunez MI, Rosen DG, Ludes-Meyers JH, et al. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer\u20082005; 5: 64.","DOI":"10.1186\/1471-2407-5-64"},{"key":"2022061700292561900_B19","doi-asserted-by":"crossref","unstructured":"Iliopoulos D, Guler G, Han SY, et al. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene\u20082005; 24: 1625\u201333.","DOI":"10.1038\/sj.onc.1208398"},{"key":"2022061700292561900_B20","doi-asserted-by":"crossref","unstructured":"Wei SH, Balch C, Paik HH, et al. Prognostic DNA methylation biomarkers in ovarian cancer. Clin Cancer Res\u20082006; 12: 2788\u201394.","DOI":"10.1158\/1078-0432.CCR-05-1551"},{"key":"2022061700292561900_B21","unstructured":"Langdon SP, Lawrie SS, Hay FG, et al. Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res\u20081988; 48: 6166\u201372."},{"key":"2022061700292561900_B22","unstructured":"Behrens BC, Hamilton TC, Masuda H, et al. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res\u20081987; 47: 414\u20138."},{"key":"2022061700292561900_B23","unstructured":"Louie KG, Behrens BC, Kinsella TJ, et al. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res\u20081985; 45: 2110\u20135."},{"key":"2022061700292561900_B24","doi-asserted-by":"crossref","unstructured":"Minett TW, Tighe BJ, Lydon MJ, Rees DA. Requirements for cell spreading on polyHEMA coated culture substrates. Cell Biol Int Rep\u20081984; 8: 151\u20139.","DOI":"10.1016\/0309-1651(84)90082-1"},{"key":"2022061700292561900_B25","doi-asserted-by":"crossref","unstructured":"Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer\u20082003; 3: 362\u201374.","DOI":"10.1038\/nrc1075"},{"key":"2022061700292561900_B26","doi-asserted-by":"crossref","unstructured":"Manohar A, Shome SG, Lamar J, et al. \u03b13\u03b21 integrin promotes keratinocyte cell survival through activation of a MEK\/ERK signaling pathway. J Cell Sci\u20082004; 117: 4043\u201354.","DOI":"10.1242\/jcs.01277"},{"key":"2022061700292561900_B27","doi-asserted-by":"crossref","unstructured":"Zhang F, Tom CC, Kugler MC, et al. Distinct ligand binding sites in integrin \u03b13\u03b21 regulate matrix adhesion and cell-cell contact. J Cell Biol\u20082003; 163: 177\u201388.","DOI":"10.1083\/jcb.200304065"},{"key":"2022061700292561900_B28","doi-asserted-by":"crossref","unstructured":"Casey RC, Burleson KM, Skubitz KM, et al. \u03b21-Integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol\u20082001; 159: 2071\u201380.","DOI":"10.1016\/S0002-9440(10)63058-1"},{"key":"2022061700292561900_B29","unstructured":"Casey RC, Skubitz AP. CD44 and \u03b21 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metastasis\u20082000; 18: 67\u201375."},{"key":"2022061700292561900_B30","doi-asserted-by":"crossref","unstructured":"Sawada K, Radjabi AR, Shinomiya N, et al. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res\u20082007; 67: 1670\u20139.","DOI":"10.1158\/0008-5472.CAN-06-1147"},{"key":"2022061700292561900_B31","doi-asserted-by":"crossref","unstructured":"Strobel T, Cannistra SA. \u03b21-Integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol\u20081999; 73: 362\u20137.","DOI":"10.1006\/gyno.1999.5388"},{"key":"2022061700292561900_B32","doi-asserted-by":"crossref","unstructured":"Shield K, Riley C, Quinn MA, Rice GE, Ackland ML, Ahmed N. \u03b12\u03b21 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J Carcinog\u20082007; 6: 11.","DOI":"10.1186\/1477-3163-6-11"},{"key":"2022061700292561900_B33","doi-asserted-by":"crossref","unstructured":"Ahmed N, Riley C, Rice G, Quinn M. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis\u20082005; 22: 391\u2013402.","DOI":"10.1007\/s10585-005-1262-y"},{"key":"2022061700292561900_B34","doi-asserted-by":"crossref","unstructured":"Takatsuki H, Komatsu S, Sano R, Takada Y, Tsuji T. Adhesion of gastric carcinoma cells to peritoneum mediated by \u03b13\u03b21 integrin (VLA-3). Cancer Res\u20082004; 64: 6065\u201370.","DOI":"10.1158\/0008-5472.CAN-04-0321"},{"key":"2022061700292561900_B35","doi-asserted-by":"crossref","unstructured":"Ura H, Denno R, Hirata K, Yamaguchi K, Yasoshima T. Separate functions of \u03b12\u03b21 and \u03b13\u03b21 integrins in the metastatic process of human gastric carcinoma. Surg Today\u20081998; 28: 1001\u20136.","DOI":"10.1007\/BF02483952"},{"key":"2022061700292561900_B36","doi-asserted-by":"crossref","unstructured":"Bignotti E, Tassi RA, Calza S, et al. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am J Obstet Gynecol\u20082007; 196: 245 e1\u201311.","DOI":"10.1016\/j.ajog.2006.10.874"},{"key":"2022061700292561900_B37","doi-asserted-by":"crossref","unstructured":"Hapke S, Kessler H, Luber B, et al. Ovarian cancer cell proliferation and motility is induced by engagement of integrin \u03b1v\u03b23\/vitronectin interaction. Biol Chem\u20082003; 384: 1073\u201383.","DOI":"10.1515\/BC.2003.120"},{"key":"2022061700292561900_B38","doi-asserted-by":"crossref","unstructured":"Lee BH, Ruoslahti E. \u03b15\u03b21 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+\/calmodulin-dependent protein kinase IV. J Cell Biochem\u20082005; 95: 1214\u201323.","DOI":"10.1002\/jcb.20488"},{"key":"2022061700292561900_B39","doi-asserted-by":"crossref","unstructured":"Zhang Z, Vuori K, Reed JC, Ruoslahti E. The \u03b15\u03b21 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A\u20081995; 92: 6161\u20135.","DOI":"10.1073\/pnas.92.13.6161"},{"key":"2022061700292561900_B40","doi-asserted-by":"crossref","unstructured":"Sethi T, Rintoul RC, Moore SM, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med\u20081999; 5: 662\u20138.","DOI":"10.1038\/9511"},{"key":"2022061700292561900_B41","doi-asserted-by":"crossref","unstructured":"Jiang YP, Wu XH, Shi B, Wu WX, Yin GR. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol\u20082006; 103: 226\u201333.","DOI":"10.1016\/j.ygyno.2006.02.036"},{"key":"2022061700292561900_B42","doi-asserted-by":"crossref","unstructured":"Nunez MI, Ludes-Meyers J, Abba MC, et al. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res Treat\u20082005; 89: 99\u2013105.","DOI":"10.1007\/s10549-004-1474-x"},{"key":"2022061700292561900_B43","doi-asserted-by":"crossref","unstructured":"Zou K, Hosono T, Nakamura T, et al. Novel role of presenilins in maturation and transport of integrin \u03b21. Biochemistry\u20082008; 47: 3370\u20138.","DOI":"10.1021\/bi7014508"},{"key":"2022061700292561900_B44","doi-asserted-by":"crossref","unstructured":"Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2\u03b3 transcription factor. Cancer Res\u20082004; 64: 8256\u201361.","DOI":"10.1158\/0008-5472.CAN-04-2055"},{"key":"2022061700292561900_B45","doi-asserted-by":"crossref","unstructured":"Gaudio E, Palamarchuk A, Palumbo T, et al. Physical association with WWOX suppresses c-Jun transcriptional activity. Cancer Res\u20082006; 66: 11585\u20139.","DOI":"10.1158\/0008-5472.CAN-06-3376"},{"key":"2022061700292561900_B46","doi-asserted-by":"crossref","unstructured":"van der Horst EH, Degenhardt YY, Strelow A, et al. Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci U S A\u20082005; 102: 15901\u20136.","DOI":"10.1073\/pnas.0508014102"},{"key":"2022061700292561900_B47","doi-asserted-by":"crossref","unstructured":"Modzelewska K, Newman LP, Desai R, Keely PJ. Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas. J Biol Chem\u20082006; 281: 37527\u201335.","DOI":"10.1074\/jbc.M604342200"},{"key":"2022061700292561900_B48","doi-asserted-by":"crossref","unstructured":"Mahajan NP, Whang YE, Mohler JL, Earp HS. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res\u20082005; 65: 10514\u201323.","DOI":"10.1158\/0008-5472.CAN-05-1127"},{"key":"2022061700292561900_B49","doi-asserted-by":"crossref","unstructured":"Jin C, Ge L, Ding X, et al. PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction. Biochem Biophys Res Commun\u20082006; 341: 784\u201391.","DOI":"10.1016\/j.bbrc.2006.01.023"},{"key":"2022061700292561900_B50","doi-asserted-by":"crossref","unstructured":"Hiscox S, Jiang WG. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin\/\u03b2-catenin. J Cell Sci\u20081999; 112 Pt 18: 3081\u201390.","DOI":"10.1242\/jcs.112.18.3081"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/11\/4835\/2611107\/4835.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/11\/4835\/2611107\/4835.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:23:54Z","timestamp":1655429034000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/11\/4835\/549668\/WWOX-Gene-Expression-Abolishes-Ovarian-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,6,1]]},"published-print":{"date-parts":[[2009,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-2974","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22378137","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378149.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378149","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378143","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378155","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378152","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378140.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378140","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498819","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498819.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378143.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378137.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378152.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378155.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}